• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重α1-抗胰蛋白酶缺乏症(Pi Z型)的自然病史和预期寿命

Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z.

作者信息

Larsson C

出版信息

Acta Med Scand. 1978;204(5):345-51. doi: 10.1111/j.0954-6820.1978.tb08452.x.

DOI:10.1111/j.0954-6820.1978.tb08452.x
PMID:309708
Abstract

Clinical data from 246 adult Swedish individuals with severe alpha1-antitrypsin deficiency, Pi Z, diagnosed in 1963--77, were analyzed. Primary emphysema was present in 109 cases. Of 75 Pi Z patients with other types of chronic obstructive pulmonary disease (COPD), all but 7 showed signs of emphysema. Median age at onset of dyspnoea in Pi Z smokers was 40 years, compared to 53 in non-smokers (p less than 0.001). Of the Pi Z individuals over the age of 50, 19% had a diagnosis of liver cirrhosis and 15% signs of glomerular renal damage. Of 91 deceased patients, 56 died from COPD and 12 from liver disease. A greatly reduced survival was demonstrated in Pi Z individuals, regardless of sex. Smoking Pi Z individuals had a significantly lower life expectancy than Pi Z non-smokers (p less than 0.01).

摘要

对1963年至1977年间诊断出患有严重α1-抗胰蛋白酶缺乏症(Pi Z型)的246名成年瑞典人的临床数据进行了分析。109例患者存在原发性肺气肿。在75例患有其他类型慢性阻塞性肺疾病(COPD)的Pi Z患者中,除7例之外,其余患者均有肺气肿迹象。Pi Z型吸烟者出现呼吸困难的中位年龄为40岁,非吸烟者为53岁(p<0.001)。在50岁以上的Pi Z个体中,19%被诊断为肝硬化,15%有肾小球肾损伤迹象。在91例死亡患者中,56例死于COPD,12例死于肝病。无论性别如何,Pi Z个体的生存率均大幅降低。吸烟的Pi Z个体的预期寿命明显低于不吸烟的Pi Z个体(p<0.01)。

相似文献

1
Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z.严重α1-抗胰蛋白酶缺乏症(Pi Z型)的自然病史和预期寿命
Acta Med Scand. 1978;204(5):345-51. doi: 10.1111/j.0954-6820.1978.tb08452.x.
2
Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.α1抗胰蛋白酶缺乏症患者肺功能的变异性:临床相关性
Ann Intern Med. 1989 Dec 15;111(12):982-91. doi: 10.7326/0003-4819-111-12-982.
3
The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.瑞典国家严重α1-抗胰蛋白酶缺乏症患者登记册中纳入对象的临床概况。
COPD. 2015 May;12 Suppl 1:36-41. doi: 10.3109/15412555.2015.1021909.
4
[Pulmonary emphysema--lung transplantation].[肺气肿——肺移植]
Versicherungsmedizin. 1995 Dec 1;47(6):201-3.
5
Lung function studies in asymptomatic individuals with moderately (Pi SZ) and severely (Pi Z) reduced levels of alpha1-antitrypsin.α1-抗胰蛋白酶水平中度降低(Pi SZ)和重度降低(Pi Z)的无症状个体的肺功能研究。
Scand J Respir Dis. 1976;57(6):267-80.
6
Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy.慢性阻塞性肺疾病患者中的蛋白酶抑制剂:α-抗胰蛋白酶杂合子争议
Am Rev Respir Dis. 1976 May;113(5):601-6. doi: 10.1164/arrd.1976.113.5.601.
7
Smoking and intermediate alpha1-antitrypsin deficiency and lung function in middle-aged men.中年男性的吸烟、中度α1-抗胰蛋白酶缺乏与肺功能
Br Med J. 1977 Oct 8;2(6092):922-5. doi: 10.1136/bmj.2.6092.922.
8
Glomerulonephritis as late manifestation of severe alpha 1-antitrypsin deficiency.肾小球肾炎作为严重α1抗胰蛋白酶缺乏症的晚期表现。
Clin Investig. 1994 May;72(5):404-8. doi: 10.1007/BF00252839.
9
Genetics of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的遗传学
Novartis Found Symp. 2001;234:45-58; discussion 58-64.
10
alpha 2-Macroglobulin in patients with obstructive lung disease, with and without alpha 1-antitrypsin deficiency.患有和未患有α1-抗胰蛋白酶缺乏症的阻塞性肺病患者体内的α2-巨球蛋白
Clin Chim Acta. 1983 Mar 14;128(2-3):241-8. doi: 10.1016/0009-8981(83)90324-8.

引用本文的文献

1
Alpha-1 Antitrypsin Deficiency and Bronchial Asthma: Current Challenges.α-1抗胰蛋白酶缺乏症与支气管哮喘:当前挑战
Biomolecules. 2025 Jun 3;15(6):807. doi: 10.3390/biom15060807.
2
Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency.α-1抗胰蛋白酶缺乏症的诊断和治疗建议。
J Bras Pneumol. 2024 Dec 6;50(5):e20240235. doi: 10.36416/1806-3756/e20240235. eCollection 2024.
3
Twenty years of changes in the definition of early chronic obstructive pulmonary disease.早期慢性阻塞性肺疾病定义二十年的变迁
Chin Med J Pulm Crit Care Med. 2023 Jun 2;1(2):84-93. doi: 10.1016/j.pccm.2023.03.004. eCollection 2023 Jun.
4
Global 5'-UTR RNA structure regulates translation of a SERPINA1 mRNA.全球 5'-UTR RNA 结构调节 SERPINA1 mRNA 的翻译。
Nucleic Acids Res. 2022 Sep 23;50(17):9689-9704. doi: 10.1093/nar/gkac739.
5
Pulmonary Function and Respiratory Diseases in Different Genotypes of Alpha-1 Antitrypsin Deficiency.α-1抗胰蛋白酶缺乏症不同基因型中的肺功能与呼吸系统疾病
Turk Thorac J. 2022 Nov;23(6):376-382. doi: 10.5152/TurkThoracJ.2022.22001.
6
Liver-directed gene therapy attenuates progression of spontaneous and tobacco smoke-induced emphysema in α1-antitrypsin null mice.肝靶向基因治疗可减轻α1抗胰蛋白酶缺乏小鼠自发性和烟草烟雾诱导的肺气肿进展。
Mol Ther Methods Clin Dev. 2022 Apr 13;25:425-438. doi: 10.1016/j.omtm.2022.04.003. eCollection 2022 Jun 9.
7
The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening.通过筛查确定的严重α-1-抗胰蛋白酶缺乏症患者的临床病程。
Int J Chron Obstruct Pulmon Dis. 2022 Jan 5;17:43-52. doi: 10.2147/COPD.S340241. eCollection 2022.
8
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification.肝细胞癌(HCC):流行病学、病因学和分子分类。
Adv Cancer Res. 2021;149:1-61. doi: 10.1016/bs.acr.2020.10.001. Epub 2020 Nov 28.
9
Serum Levels of Glutamate-Pyruvate Transaminase, Glutamate-Oxaloacetate Transaminase and Gamma-Glutamyl Transferase in 1494 Patients with Various Genotypes for the Alpha-1 Antitrypsin Gene.1494例α-1抗胰蛋白酶基因不同基因型患者的血清谷丙转氨酶、谷草转氨酶和γ-谷氨酰转移酶水平
J Clin Med. 2020 Dec 3;9(12):3923. doi: 10.3390/jcm9123923.
10
Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US.美国商业保险和医疗保险受益的慢性阻塞性肺疾病患者中合并症与α1抗胰蛋白酶缺乏症的关联。
Int J Chron Obstruct Pulmon Dis. 2020 Oct 5;15:2389-2397. doi: 10.2147/COPD.S263297. eCollection 2020.